Status:
ENROLLING_BY_INVITATION
Dermatitis Herpetiformis Refractory to Gluten Free Diet
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Tampere University
University of Helsinki
Conditions:
Dermatitis Herpetiformis
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of the study is to find out 1. the natural course of refractory dermatitis herpetiformis and the development of possible complications 2. the strictness of gluten-free diet treatment...
Detailed Description
Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and ...
Eligibility Criteria
Inclusion
- Study patients:
- Dermatitis herpetiformis diagnosis
- Dermatitis herpetiformis rash not responding to a strict gluten-free diet after at least 3 years
- Control patients:
- Dermatitis herpetiformis diagnosis
- Dermatitis herpetiformis with good response to a gluten-free diet
Exclusion
- Study patients:
- Not following strict gluten-free diet
- Control patients:
- Not following a strict gluten-free diet
Key Trial Info
Start Date :
June 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT05998291
Start Date
June 15 2023
End Date
December 31 2026
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33101